Delivery Order SPE2DB22D2007-SPE2DB25FJ1YN
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $17,251.15 to AmerisourceBergen Drug Corp for OmniPod 5 continuous glucose monitoring pods (Generation 5) with a completion date of September 18, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The OmniPod system represents a critical medical device for diabetes management,...
- The Defense Logistics Agency awarded a $33,921.62 delivery order to AmerisourceBergen Drug Corp for OmniPod 5 continuous glucose monitoring pods (Generation 5, 5-unit packs) on September 3, 2025, with an ultimate completion date of September 4, 2025. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The products will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $8,655.56 firm fixed-price delivery order to AmerisourceBergen Drug Corp for OmniPod 5 continuous glucose monitoring pods (Generation 5, 5-pack configuration) on August 25, 2025, with completion scheduled for August 26, 2025. The contract was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,983.80 to AmerisourceBergen Drug Corp for OmniPod 5 continuous glucose monitoring pods (Generation 5) with a 5-sensor configuration. The contract was competitively awarded without set-aside designation and carries a completion date of June 10, 2025. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $23,715.24 to AmerisourceBergen Drug Corp for OmniPod 5 Dexcom G7 insulin infusion pump pods (Generation 5) with a completion date of August 28, 2025. This non-competed delivery order utilizes firm fixed pricing and will be performed at the contractor's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, is positioned as a critical vendor...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,603.61 to AmerisourceBergen Drug Corp for OmniPod 5 Dexcom G7 continuous glucose monitoring system pods (Generation 5), with performance in Conshohocken, Pennsylvania. This is a firm fixed price, competitively awarded contract with an ultimate completion date of August 21, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as the prime contractor under this...
- The Defense Logistics Agency awarded a delivery order valued at $1,790.28 to AmerisourceBergen Drug Corp for OmniPod 5 DexG7G6 Pods (Generation 5) with a completion date of June 13, 2025. This non-set-aside contract utilizes firm fixed pricing and is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99...
- The Defense Logistics Agency awarded a $1,372.91 firm fixed price delivery order to AmerisourceBergen Drug Corp for OmniPod 5 Dexcom G7 generation 5 pods on July 22, 2025, with an ultimate completion date of July 23, 2025. This competitively awarded, non-set-aside contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract issued under the company's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a competitively awarded delivery order valued at $1,566.49 for OmniPod 5 Dexcom G7 pods (Generation 5) with a 5-second delivery interval. The order, issued on September 2, 2025, with completion targeted for September 3, 2025, represents a firm fixed-price transaction with no set-aside designation. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is executed...
- The Defense Logistics Agency awarded a $2,395.34 delivery order to AmerisourceBergen Drug Corp for OmniPod 5 Dexcom G7 Generation 5 insulin infusion pods. The contract, issued on July 25, 2025, with an ultimate completion date of July 28, 2025, represents a firm fixed price procurement with no set-aside designation. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania serves as the place of performance for this medical device delivery, which supports the federal government's...
- SPE2DB22D2007Indefinite Delivery Contract
- SPE2DB22D2007-SPE2DB25FJ1YNDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,047.70 to AmerisourceBergen Drug Corp for OmniPod 5 continuous glucose monitoring pods (Generation 5) on June 2, 2025, with completion expected by June 3, 2025. This firm fixed-price delivery order, which involves no set-aside designation, will be performed at the contractor's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical procurement, is delivering specialized diabetes management medical devices through this transaction. This delivery order represents a single transaction within AmerisourceBergen Drug Corp's broader indefinite delivery contract relationship with DLA Troop Support Medical. The company holds a significant prime IDC valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle enabling the supply of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The DLA Troop Support Medical contract portfolio demonstrates AmerisourceBergen Drug Corp's extensive capability in fulfilling federal medical supply requirements across multiple therapeutic domains, supporting customers including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.0k | 6/2/25 |